You can view polls created in the following languages.
English
German
French
Spanish
Dutch
Romanian
Norwegian
Portugese
Serbo Croatian
Arabic

PDUFA reauthorization will have what effect

Quicker review times for new drug applications

Better post-marketing safety surveillance

Higher fees, but no noticeable difference in anything

All of the above

None of the above

Comments have been disabled for this poll.